The Oregon State University veterinary laboratory teamed up with a private lab to use its expertise to boost testing and tracking of the COVID-19 virus, even after its offer of help drew scant interest from state health officials.
(CDC file art)
Published by arrangement with The Lund Reporthttps://www.thelundreport.org/
Specialists at Oregon State Universitys veterinary laboratory figured they could help the state ramp up testing for coronavirus. They run a sophisticated facility with state-of-the-art testing equipment, and theyre experts atdiagnostics and tracking viruses.
But they couldnt just start running COVID-19 tests. They faced a tangle of red tape.
So they approached the Oregon Health Authority, and a lawmaker contacted Gov. Kate Browns office for help. That led nowhere. The authority did not give them any support, and Browns office did not follow up with them, according to interviews and documents obtained by The Lund Report.
The labs managers did not give up. They forged ahead, dismantling obstacles without the states help. They joined forces with a commercial medical lab in Corvallis. In a joint effort, the two labs plan to launch their first COVID-19 tests on Wednesday. The project expects to run nearly 1,000 COVID-19 a day, giving Oregon a much-needed boost in its efforts to track the virus. Right now, Oregon tests between 7,000 and 8,000 people a week, Brown said.
Oregons lack of adequate testing infrastructure has dogged the states efforts to contain the virus. State public health officials repeatedly have said the state needs more tests to halt the spread, something that Brown repeated at a news conference on Tuesday."We need to ramp up testing in every region of the state," she said.
Yet state officials did not pursue a homegrown opportunity that taps the expertise of an Oregon university research laboratory.
From the start, testing has lagged in Oregon. Initial kits from the Centers for Disease Control and Prevention were faulty, and there was a lack of supplies. The state expected all tests to be conducted at the public health lab in Hillsboro but has since allowed testing by five hospital systems, two private labs and the University of Washington. Still, the state only has results for about 30,000 people, according to an Oregon Health Authority report on Monday.
The OSU project shines a light on the difficulties faced by entities outside the public health system to help Oregon track and quell the epidemic. The Oregon Health Authority apparently failed to recognize the contribution a veterinary lab could make despite examples in other states.
University veterinary labs in at least two other states Colorado and Oklahoma have been conducting COVID-19 testing for weeks. Each can process hundreds of tests a day. Their veterinary labs unlike OSUs had help from public authorities.
Physicians lack drugs to fight the virus, and it will be a year or more before a vaccine is on the market. The only tool public health officials have right now are tests.
"Testing is an essential pillar of any public health response to a disease outbreak, Dr. Sharon Meieran, a Multnomah County commissioner and emergency room doctor, told The Lund Report in an email. It allows for case identification, contact tracing and importantly, especially in congregate settings, the ability to isolate individuals who are infected so that they do not risk infecting others. Any increase in our capacity to test for COVID-19 will aid in our ability to respond to this disease at both an individual and community level."
Experts say that the more entities that test and the quicker the results, the sooner people will isolate themselves and stop spreading the highly contagious virus.
The lack of testing from the beginning has been one of the leading causes for where we are now," said Chunhuei Chi, director of OSUs Center for Global Health.
Lab Has Diagnostic Track Record
In Oregon, the idea to get the veterinary lab involved came from the medical community in Corvallis, including Good Samaritan Regional Medical Center. Frustrated over long waits for testing results, physicians approached the Oregon Veterinary Diagnostic Laboratory at OSU last month to see if officials there could use their equipment to run COVID-19 tests. The lab was a prime candidate to help.
Any additional testing capacity that they can provide would be welcomed by the region and the state of Oregon, said Dr. Adam Brady, an infectious disease specialist and chairman of the hospitals coronavirus task force, in an email.
The lab, part of the universitys Carlson College of Veterinary Medicine, has a long history of tracking illness, like viruses in sheep and hoof and mouth disease in cattle. It works with state epidemiologists and is part of a U.S. Food and Drug Administration network of about 45 facilities nationwide that specialize in investigating animal diseases. They analyze animal blood, urine, stool and tissue samples for signs of illnesses to help the federal agency investigate complaints about tainted food and drugs.
One of the labs machines extracts genetic material from samples, usually collected via nasal swabs. The other machine analyzes the genetic material and provides the results.
This is just the sort of technology needed to conduct COVID-19 tests.
Mark Ackermann, director of the veterinary lab, wanted to help out but to run human analyses, a lab needs to be certified by the Centers for Medicare & Medicaid Services. His lab lacked that certification.
To obtain it, a lab has to meet federal standards. That process is complicated and takes time, even for a research lab that already meets other federal standards to track diseases in animals.
So Ackermann asked the Oregon Health Authority for help in smoothing the way for the veterinary lab to conduct tests on its own or work with another facility.
Agency officials visited the lab and discussed federal certification requirements, said Jonathan Modie, a spokesman for the agency. But they didnt help. Theysuggested that Ackermann contact clinical laboratories instead.
Early on, Ackermann received support from Sen. Sara Gelser, D-Corvallis, who saw the potential in the idea. On March 26, Gelser tried to enlist the support of Gov. Kate Brown by emailing Browns chief of staff, Nik Blosser, and copying other lawmakers. That email, obtained by The Lund Report, encouraged the governors office to consider an executive order allowing COVID-19 tests at research universities. Gelser pointed out that Oklahomas governor had issued such an order enabling a university veterinary lab there to participate in testing.
Would the governor consider a similar executive order so that OSU could make the same application and hopefully come online immediately, Gelser wrote, calling it a game-changer for containment efforts.
Charles Boyle, a spokesman for Brown, said the office passed along the request to the health authority. He referred a reporter to the health authority for further comment.
Ackermann said he never heard from the governors office.
Partnership Is Formed
But the lab found a way forward on its own.
At the same time that Ackermann was crashing into a regulatory wall, another lab in Corvallis was trying to conduct testing. WVT Laboratory, a commercial lab that normally analyzes toxins in urine and runs drug tests, contacted Benton Countys emergency operations center to see what it needed to do to conductCOVID-19 testing. That contact led to WVT hooking up with OSU through Dr. Bruce Thomson, a retired family physician in Corvallis who does consulting work for the county.
The two labs complemented each other.
WVT Laboratory has the necessary certification from CMS to conduct COVID-19 testing. It also has an approved records system that meets federal privacy regulations for patients. And the veterinary lab has the equipment that WVT needed to run the tests.
Less than a week after they met on April 1, the heads of the two labs decided that OSU would contribute its equipment. The university lab will extract the genetic material from tests and WVT will run the tests. After contacting the county, the pact came together quickly, said Manny Cruz, chief executive officer of WVT, which has a staff of eight people.
In an interview, Thomson gave the Oregon Health Authority credit for visiting Corvallis even though that didnt lead to anything.
I know they were pretty darn busy juggling a lot of things and felt that they just couldnt be of any help to us, Thomson said.
But in an April 4 email to Ackermann and Sen. Brian Boquist, R-Dallas, Thomson criticized the agency.
Our pursuit was not supported in any way by OHA, Thomson wrote. In spite of all the obstacles that OHA enumerated several times during an hour-long pitch by us, it now appears that the lab instrument will be up and running.
The two labs trained together for the first time Friday, with a plan to ramp up testing this week. The lab will not collect samples directly from patients. Instead, local doctors will determine who needs testing, collect samples from patients and send them to the lab for testing.Similar Efforts Elsewhere
The public-private collaboration between OSU and WVT may be unique in the U.S. Other veterinary labs involved in COVID-19 testing have official support. Those states found ways to either obtain the federal certification for the veterinary lab or they hooked the lab up with a partner with federal approval.
Last month, the diagnostic veterinary lab at Colorado State University in Fort Collins forged the path by gaining federal certification through a collaboration with the universitys student health center lab.
Kristy Pabilonia, director of the veterinary lab at Colorado State, said the student health centers lab director had the right qualifications, enabling the veterinary lab to apply for the certification, which requires audits and inspections. Usually, the federal government completes a background check and vets the director. The Colorado lab didnt need that step because the student lab director was already qualified.
The veterinary lab equipment can handle 200 tests a day.
Oklahoma State University is also running COVID-19 tests. It has five machines processing 1,000 tests a day at its diagnostic laboratory, which usually investigates animal diseases and outbreaks. The university could expand to around-the-clock testing if necessary, said Kenneth Sewell, the universitys vice president of research.
Like OSU, the veterinary lab at Oklahoma State lacked CMS certification. But it teamed up with its medical school, which is run by a certified director. The medical schools certification allows the lab to run tests.
The states governor, Kevin Stitt, also helped by signing an executive order that allowed the university to do the tests.
We became an extension or arm of the public health process so the hospitals and health care providers and pop-up specimen collection centers could send specimens to us, Sewell said. It allowed us to relieve the pressure on the department of health.
The Oregon solution came together differently. Ackermann, who avoided criticizing the health authority, said he was grateful that WVT was eager to collaborate.
They were willing to help, so lets go down that road and see where it takes us.
This story is published as part of a collaborative of news organizations across Oregon sharing stories in the public interest. Salem Reporter is part of the collaborative.
Visit link:
Without state's help, OSU lab found its own way to help COVID-19 testing - Salem Reporter
- Department of Genetic Medicine - January 6th, 2025
- Research Services | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- Patient Care | Johns Hopkins Department of Genetic Medicine - January 6th, 2025
- Specialty Clinics | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- Pediatric Genetic Medicine at Johns Hopkins Children's Center - January 6th, 2025
- Research Centers | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- About Us - Johns Hopkins Medicine - January 6th, 2025
- Graduate Programs & Training | Johns Hopkins Medicine - January 6th, 2025
- Request an Appointment | Johns Hopkins Institute of Genetic Medicine - January 6th, 2025
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- The Columns Stepping Stones in STEM Washington and Lee University - The Columns - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021